PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 9:19 AM ET

Sponsor Check › Person

LE
No photo found yet (own website and image search run after this page is viewed)

Luke Evnin

Named as an officer, director or promoter on SEC Form D filings · MA, CA · Feb 27, 2009 → Jul 31, 2023

21deals (issuers)
$1.6Breported sold
416investors
49Form D filings
2009–2023years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:17 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Luke Evnin is listed as an executive officer, director, and promoter on 49 SEC Form D filings by 21 issuers between Feb 2009 and Jul 2023. Largest by amount reported sold: MPM BioVentures 2022, L.P. (Boston, MA — pooled investment fund — 2022; $351M reported sold to 45 investors), MPM BioVentures 2014, L.P. (Cambridge, MA — pooled investment fund — 2014–2015; $347.3M reported sold to 94 investors), MPM BIOVENTURES V, L.P. (Boston, MA — pooled investment fund — 2010; $140M reported sold to 24 investors), Harpoon Therapeutics, Inc. (South San Francisco, CA — biotechnology — 2017–2018; $100.2M reported sold to 18 investors), MPM ONCOLOGY INNOVATIONS FUND LP (Cambridge, MA — pooled investment fund — 2018–2020; $98.9M reported sold to 36 investors) and 16 more (all listed below).

What this means That is a lot of deals — 21 separate companies raised money with this person listed as executive officer, director, and promoter, over about 14 years. Across those companies the filings report $1.6B sold in total.

Listed alongside Ansbert Gadicke (13 shared filings), Cameron Wheeler (11 shared filings), Briggs Morrison (9 shared filings), Daniel Hicklin (9 shared filings), David Cordo (9 shared filings) and 105 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Luke. Each name links to their own page.

The issuers belong to 4 sponsor groups: Mpm Bioventures (2 issuers, $0 reported sold, 2018), Trieza (2 issuers, $78.1M reported sold, 2016–2021), Mpm (2 issuers, $369.8M reported sold, 2014–2015) and Digitx (2 issuers, $10.5M reported sold, 2016–2023).

What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 49 public filings for Luke Evnin and found 17 differences, 6 worth asking the sponsor about: Regulator action naming a team member: ReShape Lifesciences Inc. (Aug 22, 2023); Amount sold went down between filings; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Luke Evnin has not run yet — it is joining a line of 30,637 names; searches run around the clock at the hosts' allowed rate. Searched so far: 638 names.

Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:17 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Luke Evnin..

State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:17 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

17 differences found between the filings for Luke Evnin — 6 worth asking about (compared 49 filings on Oct 24, 2026)

Worth asking · Aug 22, 2023

Regulator action naming a team member: ReShape Lifesciences Inc. (Aug 22, 2023)

A ap release dated Aug 22, 2023 names ReShape Lifesciences Inc. (related issuer). Our match estimate: 90%. The release is the source; we do not summarize its outcome here.

What this means A regulator filed or announced an action naming this person or company (or someone on the same filings). Read the release; ask the sponsor what it was and how it ended.

ReShape Lifesciences Inc. ↗ReShape Lifesciences Inc. — PartnerFacts page ↗
Sources
Note · May 10, 2013 – Nov 27, 2013

Bankruptcy case: ALL FLORIDA DELIVERY SERV. INC v. Cordo — filed May 10, 2013

United States Bankruptcy Court, S.D. Florida. docket "ALL FLORIDA DELIVERY SERV. INC v. Cordo" filed May 10, 2013, closed Nov 27, 2013. David Cordo (listed on the same filings) is listed as Defendant ("Cordo"). Our match estimate: 70%.

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, S.D. Florida. ↗David Cordo — PartnerFacts page ↗
Sources
Note · Nov 20, 2008 – Mar 4, 2010

Bankruptcy case: Jim Winkler — filed Nov 20, 2008

United States Bankruptcy Court, C.D. California docket "Jim Winkler" filed Nov 20, 2008, closed Mar 4, 2010. Jim Winkler (listed on the same filings) is listed as Debtor ("Jim Winkler"). Our match estimate: 70%.

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, C.D. California ↗Jim Winkler — PartnerFacts page ↗
Sources
Note · Oct 14, 2008 – Nov 24, 2008

Bankruptcy case: Jim Winkler — filed Oct 14, 2008

United States Bankruptcy Court, C.D. California docket "Jim Winkler" filed Oct 14, 2008, closed Nov 24, 2008. Jim Winkler (listed on the same filings) is listed as Debtor ("Jim Winkler"). Our match estimate: 70%.

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, C.D. California ↗Jim Winkler — PartnerFacts page ↗
Sources
Worth asking · Feb 12, 2010

Amount sold went down between filings — MPM BIOVENTURES V, L.P.

The Feb 12, 2010 filing says $140,048,150 sold; the Feb 12, 2010 Form D says $69,140,000 sold — $70,908,150 less.

What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.

Form D/A (earlier) · Feb 12, 2010 ↗Form D (later) · Feb 12, 2010 ↗MPM BIOVENTURES V, L.P. — PartnerFacts page ↗
Sources
Worth asking · Feb 12, 2010

Investor count went down between filings — MPM BIOVENTURES V, L.P.

The Feb 12, 2010 filing reports 24 investors; the Feb 12, 2010 Form D reports 9 investors.

What this means Investor counts normally only grow. A smaller number can mean investors left or were refunded, or a count was corrected. Ask the sponsor what happened.

Form D/A (earlier) · Feb 12, 2010 ↗Form D (later) · Feb 12, 2010 ↗MPM BIOVENTURES V, L.P. — PartnerFacts page ↗
Sources
Worth asking · Apr 10, 2013 – Feb 26, 2020

Luke Evnin appears on 5 deals that stopped filing before reaching their target

MPM ONCOLOGY INNOVATIONS FUND LP (last filing Feb 26, 2020; $98,879,004 sold of $200,000,000); MPM BIOVENTURES 2018 (B), L.P. (last filing Feb 23, 2018; $0 sold of $400,000,000); MPM BIOVENTURES 2018, L.P. (last filing Feb 22, 2018; $0 sold of $400,000,000); Vesuvius Pharmaceuticals, Inc. (last filing Jan 5, 2015; $10,225,258 sold of $33,000,000); CoStim Pharmaceuticals Inc. (last filing Apr 10, 2013; $10,005,000 sold of $22,261,000). Each has no filing in more than two years and reported under half its target sold.

What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.

MPM ONCOLOGY INNOVATIONS FUND LP — PartnerFacts page ↗MPM BIOVENTURES 2018 (B), L.P. — PartnerFacts page ↗MPM BIOVENTURES 2018, L.P. — PartnerFacts page ↗Vesuvius Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Worth asking · Aug 20, 2009 – Jul 12, 2021

6 Form Ds were filed more than 15 days after the first sale

Form D filed 350 days after the first sale — Blade Therapeutics, Inc. · Form D filed 102 days after the first sale — Frontier Medicines Corp · Form D filed 176 days after the first sale — MPM BIOVENTURES V, L.P. · Form D filed 17 days after the first sale — Frontier Medicines Corp · Form D filed 31 days after the first sale — Blade Therapeutics, Inc. · and 1 more

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Oct 24, 2019 ↗Blade Therapeutics, Inc. — PartnerFacts page ↗Form D · Jul 29, 2019 ↗Frontier Medicines Corp — PartnerFacts page ↗
Sources
Note · Feb 19, 2009 – Jul 31, 2023

17 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Redona Therapeutics, Inc. (latest filing Jul 31, 2023) · No amendment in the last 12 months on an offering that may still be open — Redona Therapeutics, Inc. (latest filing Jul 31, 2023) · No amendment in the last 12 months on an offering that may still be open — Frontier Medicines Corp (latest filing Nov 6, 2020) · No amendment in the last 12 months on an offering that may still be open — Oncorus, Inc. (latest filing Dec 20, 2019) · No amendment in the last 12 months on an offering that may still be open — Blade Therapeutics, Inc. (latest filing Oct 24, 2019) · and 12 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D/A · Jul 31, 2023 ↗Redona Therapeutics, Inc. — PartnerFacts page ↗Form D · Jul 31, 2023 ↗Form D/A · Nov 6, 2020 ↗
Sources
Worth asking · May 5, 2022 – Jun 1, 2023

Luke Evnin is no longer listed on the Jun 1, 2023 amendment — MPM BioVentures 2022, L.P.

Luke Evnin appears on the May 5, 2022 Form D (executive officer) but not on the Jun 1, 2023 Form D/A for the same offering.

What this means People leave, and the issuer must list only current officers, directors and promoters. It is still worth asking why this person left and who replaced them.

Form D · May 5, 2022 ↗Form D/A · Jun 1, 2023 ↗Luke Evnin — PartnerFacts page ↗MPM BioVentures 2022, L.P. — PartnerFacts page ↗
Sources
Note · Jul 26, 2013 – Jun 16, 2022

11 offerings changed their target amount between filings

Offering amount changed between filings — Redona Therapeutics, Inc. · Offering amount lowered between filings — Werewolf Therapeutics, Inc. · Offering amount lowered between filings — MPM ONCOLOGY INNOVATIONS FUND LP · Offering amount changed between filings — Oncorus, Inc. · Offering amount changed between filings — Amphivena Therapeutics, Inc. · and 6 more

What this means Targets change as deals grow or shrink. Ask whether later money has the same terms.

Form D (earlier) · Sep 6, 2018 ↗Form D/A (later) · Jun 16, 2022 ↗Redona Therapeutics, Inc. — PartnerFacts page ↗Form D (earlier) · Aug 15, 2019 ↗
Sources
Note · Jul 26, 2013 – May 4, 2015

Minimum investment changed between filings — Amphivena Therapeutics, Inc.

The Jul 26, 2013 filing lists a minimum of $134,623; the May 4, 2015 Form D/A lists $0.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D (earlier) · Jul 26, 2013 ↗Form D/A (later) · May 4, 2015 ↗Amphivena Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Jul 26, 2013 – Dec 19, 2018

Industry group changed between filings — Amphivena Therapeutics, Inc.

"Biotechnology" (Jul 26, 2013 to Jul 26, 2017); then "Other Health Care" (Dec 19, 2018).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Jul 26, 2013 ↗Form D · Dec 19, 2018 ↗Amphivena Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Jul 26, 2013 – May 4, 2015

Reported revenue range changed between filings — Amphivena Therapeutics, Inc.

"No Revenues" (Jul 26, 2013); then "Decline to Disclose" (May 4, 2015).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Jul 26, 2013 ↗Form D/A · May 4, 2015 ↗Amphivena Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Jun 24, 2021

Same name, different state: "Luke Evnin" (WA) is a separate record

This page covers filings where the address state is MA or CA. A separate record, "Luke Evnin" with address state WA, is listed on 1 filing — most recently by Umoja Biopharma, Inc. (Jun 24, 2021). Both records have filings in the same period (Jun 24, 2021).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Luke Evnin (WA) — PartnerFacts page ↗Form D · Jun 24, 2021 ↗Umoja Biopharma, Inc. — PartnerFacts page ↗Luke Evnin (MA,CA) — this page ↗
Sources
Note · May 29, 2014 – Jun 1, 2023

6 address changes between filings

Address moved from Cambridge, MA to Boston, MA — MPM BioVentures 2022, L.P. · Address moved from Cambridge, MA to Watertown, MA — Redona Therapeutics, Inc. · Address moved from San Francisco, CA to South San Francisco, CA — Amphivena Therapeutics, Inc. · Address moved from South San Francisco, CA to San Francisco, CA — Amphivena Therapeutics, Inc. · Address moved from Boston, MA to Cambridge, MA — Potenza Therapeutics, Inc. · and 1 more

What this means Businesses move. If you were told one city and the forms say another, ask which is current.

Form D · May 5, 2022 ↗Form D/A · Jun 1, 2023 ↗MPM BioVentures 2022, L.P. — PartnerFacts page ↗Form D · Sep 6, 2018 ↗
Sources
Note · Feb 27, 2009 – Jul 31, 2023

Luke Evnin is listed with 2 different address states: MA, CA

MA on 34 filings (Feb 27, 2009 to Jul 31, 2023); CA on 15 filings (Jul 26, 2013 to Jul 12, 2021).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · Feb 27, 2009 ↗Form D · Jul 26, 2013 ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

2 of 32 offerings report sales commissions totalling $757,444; 0 report finder's fees; 1 reports proceeds to related persons totalling $100,000. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Jul 31, 2023 D/A
Redona Therapeutics, Inc.
File 021-320722
$0$0$0None listed on this filingEDGAR ↗
Jul 31, 2023 D
Redona Therapeutics, Inc.
File 021-488348
$0$0$0None listed on this filingEDGAR ↗
May 5, 2022 D
MPM BioVentures 2022, L.P.
File 021-444554
$0$0$0None listed on this filingEDGAR ↗
Jul 12, 2021 D
Frontier Medicines Corp
File 021-405861
$0$0$0None listed on this filingEDGAR ↗
Jan 7, 2021 D
Werewolf Therapeutics, Inc.
File 021-385514
$0$0$0None listed on this filingEDGAR ↗
Nov 6, 2020 D/A
Frontier Medicines Corp
File 021-345214
$0$0$0None listed on this filingEDGAR ↗
Aug 13, 2020 D/A
Werewolf Therapeutics, Inc.
File 021-346661
$0$0$0None listed on this filingEDGAR ↗
Feb 26, 2020 D/A
MPM ONCOLOGY INNOVATIONS FUND LP
File 021-315855
$0 (est.)$0$0 (est.)
Certain persons named in Item 3 or affiliate(s) thereof may receive payments deemed to be made from the proceeds of the offering, including management fees. The amount of such payments cannot be estimated at this time.
None no CRD number reported
via UBS Financial Services Inc. (CRD 8174 ↗)
EDGAR ↗
Dec 20, 2019 D/A
Oncorus, Inc.
File 021-347029
$0$0$0None listed on this filingEDGAR ↗
Oct 24, 2019 D
Blade Therapeutics, Inc.
File 021-351771
$0$0$0N/A no CRD number reportedEDGAR ↗
Oct 24, 2019 D
Blade Therapeutics, Inc.
File 021-351778
$0$0$0N/A no CRD number reportedEDGAR ↗
Dec 19, 2018 D
Amphivena Therapeutics, Inc.
File 021-328368
$0$0$0None listed on this filingEDGAR ↗
Nov 26, 2018 D
Harpoon Therapeutics, Inc.
File 021-326493
$0$0$0None listed on this filingEDGAR ↗
Sep 21, 2018 D/A
Oncorus, Inc.
File 021-261269
$0$0$0None listed on this filingEDGAR ↗
Feb 23, 2018 D
MPM BIOVENTURES 2018 (B), L.P.
File 021-306340
$0$0$0 (est.)
Certain persons named in Item 3 or affiliate(s) thereof may receive payments deemed to be made from the proceeds of the offering, including management fees. The amount of such payments cannot be estimated at this time.
None listed on this filingEDGAR ↗
Feb 22, 2018 D
MPM BIOVENTURES 2018, L.P.
File 021-306245
$0$0$0 (est.)
Certain persons named in Item 3 or affiliate(s) thereof may receive payments deemed to be made from the proceeds of the offering, including management fees. The amount of such payments cannot be estimated at this time.
None listed on this filingEDGAR ↗
Dec 29, 2017 D
Potenza Therapeutics, Inc.
File 021-301945
$0$0$0None listed on this filingEDGAR ↗
Jul 26, 2017 D
Amphivena Therapeutics, Inc.
File 021-291539
$0$0$0None listed on this filingEDGAR ↗
Jun 26, 2017 D/A
Amphivena Therapeutics, Inc.
File 021-200287
$0$0$100,000None listed on this filingEDGAR ↗
Jun 6, 2017 D
Harpoon Therapeutics, Inc.
File 021-288173
$0$0$0None listed on this filingEDGAR ↗
Jan 19, 2017 D
Maverick Therapeutics Inc.
File 021-278798
$0$0$0None listed on this filingEDGAR ↗
Dec 5, 2016 D
Trieza Therapeutics, Inc.
File 021-275660
$0$0$0None listed on this filingEDGAR ↗
Dec 5, 2016 D
Trieza Therapeutics, Inc.
File 021-275662
$0$0$0None listed on this filingEDGAR ↗
Aug 4, 2016 D
DigiTx Partners LLC
File 021-268334
$0$0$0None listed on this filingEDGAR ↗
Jun 20, 2016 D
Blade Therapeutics, Inc.
File 021-265375
$0$0$0None listed on this filingEDGAR ↗
Mar 17, 2016 D/A
Potenza Therapeutics, Inc.
File 021-229558
$0$0$0None listed on this filingEDGAR ↗
Jul 9, 2015 D/A
MPM BioVentures 2014, L.P.
File 021-218237
$140,000$0$0
An affiliate of the General Partner is entitled to a management fee payable by certain of the Issuers.
Dayna Gant BrokerCheck CRD 2126552 ↗
via Apple Lane Group LLC (CRD 129331 ↗)
EDGAR ↗
Mar 24, 2015 D/A
MPM Bio 2014 NVS Strategic Fund, L.P.
File 021-218238
$0$0$0
An affiliate of the General Partner is entitled to a management fee payable by the Issuer.
None listed on this filingEDGAR ↗
Jan 5, 2015 D
Vesuvius Pharmaceuticals, Inc.
File 021-231374
$0$0$0None listed on this filingEDGAR ↗
Apr 10, 2013 D
CoStim Pharmaceuticals Inc.
File 021-194766
$0$0$0None listed on this filingEDGAR ↗
Feb 12, 2010 D
MPM BIOVENTURES V, L.P.
File 021-138701
$0$0$0
A portion of the proceeds will be used to pay various fees and expenses to the General Partner over the life of the partnership, payable to MPM BioVentures V GP LLC, which serves as the sole General Partner of the Issuer.
None listed on this filingEDGAR ↗
Feb 27, 2009 D
ReShape Lifesciences Inc.
File 021-92974
$617,444$0$0Canaccord Adams Inc. BrokerCheck CRD 1020 ↗EDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 21

Every issuer that named Luke Evnin on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

RT
Biotechnology

Redona Therapeutics, Inc.

Watertown, MA · Sep 6, 2018 → Jul 31, 2023 · 4 filings
  • Jul 31, 2023 · D/A · $60,825,939 sold of $76,942,575 · 11 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 31, 2023 · D · $5,953,898 sold of $11,907,796 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 16, 2022 · D/A · $60,825,939 sold of $76,942,575 · 11 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 6, 2018 · D · $25,069,279 sold of $65,185,644 · 7 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $60.8M from 11 investors (79% of the $76.9M target) as of the latest filing. Luke is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

MB
Pooled Investment Fund

MPM BioVentures 2022, L.P.

Boston, MA · May 5, 2022
  • May 5, 2022 · D · $0 sold of Indefinite · 0 investors · min. No minimum reported · role: Executive Officer (MANAGING MEMBER OF THE GENERAL PARTNER OF THE ISSUER.) EDGAR ↗

Raised $351M from 45 investors as of the latest filing. Luke is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

FM
Biotechnology

Frontier Medicines Corp

South San Francisco, CA · Jul 29, 2019 → Jul 12, 2021 · 3 filings
  • Jul 12, 2021 · D · $88,499,972 sold of $88,499,972 · 17 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 6, 2020 · D/A · $66,999,999 sold of $67,000,000 · 31 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 29, 2019 · D · $33,500,000 sold of $67,000,000 · 31 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $88.5M from 31 investors (100% of the $88.5M target) as of the latest filing. Luke is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

WT
Pharmaceuticals · group: Trieza

Werewolf Therapeutics, Inc.

Cambridge, MA · Aug 15, 2019 → Jan 7, 2021 · 3 filings
  • Jan 7, 2021 · D · $72,069,999 sold of $72,069,999 · 19 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 13, 2020 · D/A · $56,172,597 sold of $56,172,597 · 10 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 15, 2019 · D · $31,572,600 sold of $57,672,595 · 9 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $72.1M from 19 investors (100% of the $72.1M target) as of the latest filing. Luke is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

MO
Pooled Investment Fund

MPM ONCOLOGY INNOVATIONS FUND LP

Cambridge, MA · Jun 29, 2018 → Feb 26, 2020 · 3 filings
  • Feb 26, 2020 · D/A · $98,879,004 sold of $98,879,004 · 36 investors · min. No minimum reported · role: Executive Officer, Promoter (Dr. Evnin is the Manager of the General Partner of the Issuer.) EDGAR ↗
  • Jul 1, 2019 · D/A · $52,650,002 sold of $200,000,000 · 31 investors · min. No minimum reported · role: Executive Officer, Promoter (Dr. Evnin is the Manager of the General Partner of the Issuer.) EDGAR ↗
  • Jun 29, 2018 · D · $0 sold of $200,000,000 · 0 investors · min. No minimum reported · role: Executive Officer, Promoter (Dr. Evnin is the Manager of the General Partner of the Issuer.) EDGAR ↗

Raised $98.9M from 36 investors (100% of the $98.9M target) as of the latest filing. Luke is listed as executive officer, promoter on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

O
Other

Oncorus, Inc.

Cambridge, MA · Apr 14, 2016 → Dec 20, 2019 · 6 filings
  • Dec 20, 2019 · D/A · $53,761,497 sold of $89,602,491 · 30 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 20, 2019 · D · $42,123,626 sold of $79,551,797 · 21 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 21, 2018 · D/A · $61,335,083 sold of $61,425,089 · 17 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 14, 2016 · D/A · $18,722,589 sold of $61,425,089 · 17 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 5, 2016 · D/A · $17,522,499 sold of $59,120,000 · 16 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 14, 2016 · D · $4,612,500 sold of $33,000,000 · 9 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $61.3M from 30 investors (68% of the $89.6M target) as of the latest filing. Luke is listed as director on 6 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

BT
Biotechnology · group: Cerimon

Blade Therapeutics, Inc.

South San Francisco, CA · Jun 20, 2016 → Oct 24, 2019 · 3 filings
  • Oct 24, 2019 · D · $11,980,376 sold of $23,960,737 · 21 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 24, 2019 · D · $37,999,992 sold of $49,999,999 · 10 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 20, 2016 · D · $27,069,454 sold of $45,365,000 · 10 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $38M from 21 investors (100% of the $24M target) as of the latest filing. Luke is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AT
Other Health Care

Amphivena Therapeutics, Inc.

South San Francisco, CA · Jul 26, 2013 → Dec 19, 2018 · 5 filings
  • Dec 19, 2018 · D · $38,694,170 sold of $50,000,000 · 15 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 26, 2017 · D · $7,000,000 sold of $7,000,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 26, 2017 · D/A · $19,499,999 sold of $19,500,000 · 4 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 4, 2015 · D/A · $14,000,000 sold of $14,000,000 · 4 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 26, 2013 · D · $4,200,000 sold of $4,200,000 · 4 investors · min. $134,623 · role: Director EDGAR ↗

Raised $38.7M from 15 investors (77% of the $50M target) as of the latest filing. Luke is listed as director on 5 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

HT
Biotechnology

Harpoon Therapeutics, Inc.

South San Francisco, CA · Jun 6, 2017 → Nov 26, 2018 · 2 filings
  • Nov 26, 2018 · D · $69,999,993 sold of $69,999,993 · 17 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 6, 2017 · D · $25,185,208 sold of $45,185,208 · 7 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $100.2M from 18 investors (100% of the $70M target) as of the latest filing. Luke is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

MB
Pooled Investment Fund · group: Mpm Bioventures

MPM BIOVENTURES 2018 (B), L.P.

Cambridge, MA · Feb 23, 2018
  • Feb 23, 2018 · D · $0 sold of $400,000,000 · 0 investors · min. No minimum reported · role: Executive Officer, Promoter (Mr. Evnin is the Principal Managing Director of the Managing Member of the General Partner of the Issuer.) EDGAR ↗

No sales reported yet as of the latest filing. Luke is listed as executive officer, promoter.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

MB
Pooled Investment Fund · group: Mpm Bioventures

MPM BIOVENTURES 2018, L.P.

Cambridge, MA · Feb 22, 2018
  • Feb 22, 2018 · D · $0 sold of $400,000,000 · 0 investors · min. No minimum reported · role: Executive Officer, Promoter (Mr. Evnin is the Principal Managing Director of the Managing Member of the General Partner of the Issuer.) EDGAR ↗

No sales reported yet as of the latest filing. Luke is listed as executive officer, promoter.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

PT
Pharmaceuticals

Potenza Therapeutics, Inc.

Cambridge, MA · Dec 5, 2014 → Dec 29, 2017 · 3 filings
  • Dec 29, 2017 · D · $5,000,000 sold of $5,000,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 17, 2016 · D/A · $30,000,000 sold of $38,000,000 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 5, 2014 · D · $15,000,000 sold of $38,000,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $30M from 6 investors (100% of the $5M target) as of the latest filing. Luke is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

MT
Biotechnology

Maverick Therapeutics Inc.

Brisbane, CA · Jan 19, 2017
  • Jan 19, 2017 · D · $56,000,000 sold of $56,000,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $56M from 5 investors (100% of the $56M target) as of the latest filing. Luke is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

TT
Pharmaceuticals · group: Trieza

Trieza Therapeutics, Inc.

Cambridge, MA · Dec 5, 2016 → Dec 5, 2016 · 2 filings
  • Dec 5, 2016 · D · $5,999,000 sold of $5,999,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 5, 2016 · D · $1 sold of $1 · 5 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $6M from 5 investors (100% of the $6M target) as of the latest filing. Luke is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

DP
Other Technology · group: Digitx

DigiTx Partners LLC

South San Francisco, CA · Aug 4, 2016
  • Aug 4, 2016 · D · $10,500,000 sold of $21,000,000 · 4 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $10.5M from 4 investors (50% of the $21M target) as of the latest filing. Luke is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Technology / 506(b) (17,390 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

MB
Pooled Investment Fund · group: Mpm

MPM BioVentures 2014, L.P.

Cambridge, MA · May 29, 2014 → Jul 9, 2015 · 3 filings
  • Jul 9, 2015 · D/A · $347,270,750 sold of $347,270,750 · 94 investors · min. No minimum reported · role: Director (Principal Managing Director of MPM BioVentures 2014 LLC) EDGAR ↗
  • May 22, 2015 · D/A · $346,170,750 sold of $346,170,750 · 92 investors · min. No minimum reported · role: Director (Principal Managing Director of MPM BioVentures 2014 LLC) EDGAR ↗
  • May 29, 2014 · D · $0 sold of $380,000,000 · 0 investors · min. No minimum reported · role: Director (Principal Managing Director of MPM BioVentures 2014 LLC) EDGAR ↗

Raised $347.3M from 94 investors (100% of the $347.3M target) as of the latest filing. Luke is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

MB
Pooled Investment Fund · group: Mpm

MPM Bio 2014 NVS Strategic Fund, L.P.

Boston, MA · May 29, 2014 → Mar 24, 2015 · 2 filings
  • Mar 24, 2015 · D/A · $22,500,000 sold of $22,500,000 · 1 investors · min. No minimum reported · role: Director (Principal Managing Director of MPM BioVentures 2014 LLC) EDGAR ↗
  • May 29, 2014 · D · $0 sold of $15,000,000 · 0 investors · min. No minimum reported · role: Director (Principal Managing Director of MPM BioVentures 2014 LLC) EDGAR ↗

Raised $22.5M from 1 investor (100% of the $22.5M target) as of the latest filing. Luke is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

VP
Pharmaceuticals

Vesuvius Pharmaceuticals, Inc.

Boston, MA · Jan 5, 2015
  • Jan 5, 2015 · D · $10,225,258 sold of $33,000,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $10.2M from 5 investors (31% of the $33M target) as of the latest filing. Luke is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CP
Pharmaceuticals

CoStim Pharmaceuticals Inc.

Boston, MA · Apr 10, 2013
  • Apr 10, 2013 · D · $10,005,000 sold of $22,261,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $10M from 5 investors (45% of the $22.3M target) as of the latest filing. Luke is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

MB
Pooled Investment Fund

MPM BIOVENTURES V, L.P.

Boston, MA · Feb 12, 2010 → Feb 12, 2010 · 2 filings
  • Feb 12, 2010 · D/A · $140,048,150 sold of Indefinite · 24 investors · min. No minimum reported · role: Promoter (MEMBER OF THE MANAGING MEMBER) EDGAR ↗
  • Feb 12, 2010 · D · $69,140,000 sold of Indefinite · 9 investors · min. No minimum reported · role: Promoter (MEMBER OF THE MANAGING MEMBER) EDGAR ↗

Raised $140M from 24 investors as of the latest filing. Luke is listed as promoter on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

RL
Other Health Care

ReShape Lifesciences Inc.

San Clemente, CA · Feb 27, 2009
  • Feb 27, 2009 · D · $15,896,351 sold of $16,855,280 · 33 investors · min. $5,000 · role: Director EDGAR ↗

Raised $61M from 41 investors (100% of the $16.9M target) as of the latest filing. Luke is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Other pages with the same name (1)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Luke Evnin — WA, 1 issuer, Jun 24, 2021 → Jun 24, 2021 · no shared issuer

People around Luke 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

MA
Management entity

MPM Asset Management LLC

Promoter · 5 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Luke Evnin. Their page shows their other deals.

MB
Management entity

MPM BioVentures 2014 LLC

Promoter · 5 shared filings (2 issuers)

Listed on the same filings as Luke Evnin. Their page shows their other deals.

MB
Management entity

MPM BioVentures 2014 GP LLC

Promoter · 3 shared filings (1 issuer)

Listed on the same filings as Luke Evnin. Their page shows their other deals.

MO
Management entity

MPM Oncology Innovations Fund GP LLC

Executive Officer, Promoter · 3 shared filings (1 issuer)

Listed on the same filings as Luke Evnin. Their page shows their other deals.

MB
Management entity

MPM BIOVENTURES V LLC

Promoter · 2 shared filings (1 issuer)

Listed on the same filings as Luke Evnin. Their page shows their other deals.

MB
Management entity

MPM BIOVENTURES V GP LLC

Promoter · 2 shared filings (1 issuer)

Listed on the same filings as Luke Evnin. Their page shows their other deals.

MB
Management entity

MPM BioVentures 2018 GP LLC

Executive Officer, Promoter · 2 shared filings (2 issuers)

Listed on the same filings as Luke Evnin. Their page shows their other deals.

MB
Management entity

MPM BIOVENTURES 2022 GP LLC

Promoter · 1 shared filing (1 issuer)

Listed on the same filings as Luke Evnin. Their page shows their other deals.

AG
No photo found yet (own website and image search run after this page is viewed)
Person

Ansbert Gadicke

Promoter, Director, Executive Officer · 13 shared filings (7 issuers) · also on 14 other issuers

Ansbert Gadicke is on 21 issuers in total — a repeat sponsor. Their page lists every one.

CW
No photo found yet (own website and image search run after this page is viewed)
Person

Cameron Wheeler

Director · 11 shared filings (3 issuers) · also on 6 other issuers

Cameron Wheeler is on 9 issuers in total — a repeat sponsor. Their page lists every one.

BM
No photo found yet (own website and image search run after this page is viewed)
Person

Briggs Morrison

Director · 9 shared filings (3 issuers) · also on 4 other issuers

Briggs Morrison is on 7 issuers in total — a repeat sponsor. Their page lists every one.

DC
No photo found yet (own website and image search run after this page is viewed)
Person

David Cordo

Executive Officer · 9 shared filings (4 issuers) · also on 4 other issuers

David Cordo is on 8 issuers in total — a repeat sponsor. Their page lists every one.

DH
No photo found yet (own website and image search run after this page is viewed)
Person

Daniel Hicklin

Executive Officer, Director · 9 shared filings (4 issuers)

Listed on the same filings as Luke Evnin. Their page shows their other deals.

TF
No photo found yet (own website and image search run after this page is viewed)
Person

Todd Foley

Director, Executive Officer, Promoter · 7 shared filings (4 issuers) · also on 15 other issuers

Todd Foley is on 19 issuers in total — a repeat sponsor. Their page lists every one.

MF
No photo found yet (own website and image search run after this page is viewed)
Person

Mitchell Finer

Executive Officer, Director · 6 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Luke Evnin. Their page shows their other deals.

AL
No photo found yet (own website and image search run after this page is viewed)
Person

Alon Lazarus

Director · 6 shared filings (2 issuers) · also on 5 other issuers

Alon Lazarus is on 7 issuers in total — a repeat sponsor. Their page lists every one.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

James Scopa

Director · 5 shared filings (2 issuers)

Listed on the same filings as Luke Evnin. Their page shows their other deals.

KS
No photo found yet (own website and image search run after this page is viewed)
Person

Kazumi Shiosaki

Director, Executive Officer · 5 shared filings (2 issuers) · also on 2 other issuers

Listed on the same filings as Luke Evnin. Their page shows their other deals.

JG
No photo found yet (own website and image search run after this page is viewed)
Person

Jeanmarie Guenot

Executive Officer, Director · 5 shared filings (1 issuer)

Listed on the same filings as Luke Evnin. Their page shows their other deals.

PG
No photo found yet (own website and image search run after this page is viewed)
Person

Phil Gutry

Director · 4 shared filings (3 issuers)

Listed on the same filings as Luke Evnin. Their page shows their other deals.

SA
No photo found yet (own website and image search run after this page is viewed)
Person

Sakae Asanuma

Director · 4 shared filings (2 issuers) · also on 4 other issuers

Sakae Asanuma is on 6 issuers in total — a repeat sponsor. Their page lists every one.

MS
No photo found yet (own website and image search run after this page is viewed)
Person

Michal Silverberg

Director · 4 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Luke Evnin. Their page shows their other deals.

AO
No photo found yet (own website and image search run after this page is viewed)
Person

Arnold L. Oronsky

Director · 4 shared filings (2 issuers) · also on 13 other issuers

Arnold L. Oronsky is on 15 issuers in total — a repeat sponsor. Their page lists every one.

JN
No photo found yet (own website and image search run after this page is viewed)
Person

Janwillem Naesens

Director · 3 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Luke Evnin. Their page shows their other deals.

WR
No photo found yet (own website and image search run after this page is viewed)
Person

Wendye Robbins

Executive Officer, Director · 3 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Luke Evnin. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

James Scopa

Director · 3 shared filings (1 issuer) · also on 6 other issuers

James Scopa is on 7 issuers in total — a repeat sponsor. Their page lists every one.

MN
No photo found yet (own website and image search run after this page is viewed)
Person

Marian Nakada

Director · 3 shared filings (2 issuers) · also on 4 other issuers

Marian Nakada is on 6 issuers in total — a repeat sponsor. Their page lists every one.

CD
No photo found yet (own website and image search run after this page is viewed)
Person

Cynthia Seidel-Dugan

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Luke Evnin. Their page shows their other deals.

RL
No photo found yet (own website and image search run after this page is viewed)
Person

Reid Leonard

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Luke Evnin. Their page shows their other deals.

PV
No photo found yet (own website and image search run after this page is viewed)
Person

Peter Van Vlasselaer

Director · 3 shared filings (1 issuer)

Listed on the same filings as Luke Evnin. Their page shows their other deals.

WS
No photo found yet (own website and image search run after this page is viewed)
Person

William V. Slattery

Director · 3 shared filings (1 issuer)

Listed on the same filings as Luke Evnin. Their page shows their other deals.

MR
No photo found yet (own website and image search run after this page is viewed)
Person

Marc Recht

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Luke Evnin. Their page shows their other deals.

TC
No photo found yet (own website and image search run after this page is viewed)
Person

Thomas Chalberg

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Luke Evnin. Their page shows their other deals.

OL
No photo found yet (own website and image search run after this page is viewed)
Person

Othman Laraki

Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Luke Evnin. Their page shows their other deals.

PB
No photo found yet (own website and image search run after this page is viewed)
Person

Patrick Baeuerle

Director · 3 shared filings (2 issuers)

Listed on the same filings as Luke Evnin. Their page shows their other deals.

TA
No photo found yet (own website and image search run after this page is viewed)
Person

Theodore Ashburn

Executive Officer, Director · 3 shared filings (1 issuer)

Listed on the same filings as Luke Evnin. Their page shows their other deals.

CQ
No photo found yet (own website and image search run after this page is viewed)
Person

Christophe Queva

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Luke Evnin. Their page shows their other deals.

JD
No photo found yet (own website and image search run after this page is viewed)
Person

Johannes Hermann, Ph.D.

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Luke Evnin. Their page shows their other deals.

CD
No photo found yet (own website and image search run after this page is viewed)
Person

Chris Varma, Ph.D.

Executive Officer, Director · 3 shared filings (1 issuer)

Listed on the same filings as Luke Evnin. Their page shows their other deals.

The team behind the deals

MB
Sponsor group

Mpm Bioventures

2 issuers · 2 filings · $0 reported sold · 2018–2018

One team, 2 deal companies. Luke Evnin is listed on 2 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Luke Evnin.

T
Sponsor group

Trieza

2 issuers · 5 filings · $78.1M reported sold · 2016–2021

One team, 2 deal companies. Luke Evnin is listed on 2 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Luke Evnin.

M
Sponsor group

Mpm

2 issuers · 5 filings · $369.8M reported sold · 2014–2015

One team, 2 deal companies. Luke Evnin is listed on 2 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Luke Evnin.

D
Sponsor group

Digitx

2 issuers · 2 filings · $10.5M reported sold · 2016–2023

One team, 2 deal companies. Luke Evnin is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Luke Evnin.

C
Sponsor group

Cerimon

3 issuers · 9 filings · $137.2M reported sold · 2009–2025

One team, 3 deal companies. Luke Evnin is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Luke Evnin.

Same business address

51 other issuers file from the same address (first 50 shown)

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Business registration (state registry / Secretary of State)

Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).

Adviser registration (Form ADV)

A person is never an adviser firm. 2 of the 21 issuers this person is listed on match a Form ADV adviser (searched 24,962 advisers as of Oct 2, 2026): MPM BioVentures 2014, L.P., MPM Bio 2014 NVS Strategic Fund, L.P..

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Luke Evnin by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 21 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Luke Evnin is listed on: none on file. No website or social profile named in MPM BIOVENTURES V, L.P.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #364,331 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Boston, MA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗Massachusetts MassCourts ↗California — find the county court ↗Los Angeles Superior Court case search ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

Massachusetts Secretary of State business search ↗California Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Luke Evnin appears on a new Form D, or when a court case or SEC action is matched to them. See plans →